
josem706
Community MemberSteve posted an update 3 hours ago
🚀 Eli Lilly’s Semaglutide/GLP-1 PillBreakthrough Development
- Eli Lilly’s oral GLP-1 pill (orforglipron) just reported strong Phase 3 results.
- Patients lost about 12–13% of body weight (~27 lbs) over 72 weeks, with diabetic trial groups showing around 10% loss plus major A1C reductions.
- Lilly plans to submit the drug to regulators globally by…
Steve posted an update 12 hours ago
🟩 NVDA Earnings Preview (Q2 FY2026 – reporting tomorrow)
Date: Aug 27, 2025 (after market close)
1. Consensus Estimates (Wall Street expectations)
- EPS: Around $2.80–$2.95 per share (GAAP diluted EPS may vary depending on investments/mark-to-market).
- Revenue: Roughly $28.5B – $29B
- (up dramatically vs. ~$13.5B same quarter last year, driven by AI…
Steve posted an update 17 hours ago
📦 Tariffs Hit Global Mail: What It Means for Stocks
Headline Recap:
Postal services around the world have begun suspending shipments to the U.S. as expanded tariffs take effect on packages under $800—a category that was previously exempt. Starting August 29th, these parcels will face full tariff rates.
🔑 Why It Matters
- Small Package Trade Flow…
- Load More